Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome. (Record no. 30477543)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01911 a2200553 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518075919.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202011s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2168-6084 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1001/jamadermatol.2019.4141 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Zhang, April |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20201103 |
| 245 00 - TITLE STATEMENT | |
| Title | Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | JAMA dermatology |
| Date of publication, distribution, etc. | 02 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 196-200 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Case Reports; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Brazil |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Child |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Child, Preschool |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ErbB Receptors |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Erlotinib Hydrochloride |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunosuppressive Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infant |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Keratoderma, Palmoplantar |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Kinase Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Signal Transduction |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sirolimus |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Syndrome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | TOR Serine-Threonine Kinases |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Duchatelet, Sabine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lakdawala, Nikita |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tower, Richard L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Diamond, Carrie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marathe, Kalyani |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hill, India |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Richard, Gabriele |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Diab, Yaser |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kirkorian, Anna Yasmine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Watanabe, Flora |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Siegel, Dawn H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hovnanian, Alain |
| 773 0# - HOST ITEM ENTRY | |
| Title | JAMA dermatology |
| Related parts | vol. 156 |
| -- | no. 2 |
| -- | p. 196-200 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1001/jamadermatol.2019.4141">https://doi.org/10.1001/jamadermatol.2019.4141</a> |
| Public note | Available from publisher's website |
No items available.